Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_assertion type Assertion NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_head.
- NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_assertion description "[The vaccines used were recombinant vaccinia virus containing the transgenes for CEA and three T-cell costimulatory molecules [B7-1, ICAM-1, and LFA-3, designated recombinant vaccinia (rV)-CEA/TRICOM], with each transgene under the control of individual poxvirus promoters, and a replication-defective avipox virus (fowlpox; rF) containing the same four transgenes (designated rF-CEA/TRICOM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_provenance.
- NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_assertion evidence source_evidence_literature NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_provenance.
- NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_assertion SIO_000772 12384537 NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_provenance.
- NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_assertion wasDerivedFrom befree-20140225 NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_provenance.
- NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_assertion wasGeneratedBy ECO_0000203 NP876982.RA1g6E2b9qk-Z1q8EqxPxwkb5xVD_TdUnJbU0PbP3Lhe0130_provenance.